Furthermore, EMT promoted immune escape by inducing CD70 in NSCLC as shown by [38] and the molecule was also reported to be upregulated in EGFR mutant NSCLC cells that have undergone EMT, where drug-resistant CD70 + tumors were successfully targeted with CD70-Antibody–drug-conjugates, CAR-T Cells, and NK-CARs [36]. Here, EGFR is linked to non-small cell lung carcinoma.